• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮与肾素检测用于原发性醛固酮增多症筛查的对比分析。

Comparative analysis of aldosterone and renin assays for primary aldosteronism screening.

机构信息

Department of Molecular Diagnosis, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.

Product Planning, Fujirebio Inc., Tokyo, Japan.

出版信息

Sci Rep. 2024 Oct 29;14(1):26040. doi: 10.1038/s41598-024-75645-1.

DOI:10.1038/s41598-024-75645-1
PMID:39472614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11522277/
Abstract

The transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for plasma aldosterone concentration (PAC) assays has raised concerns over its impact on primary aldosteronism (PA) diagnosis. This study investigated the correlation between PAC and renin values using RIA, CLEIA, and liquid chromatography/mass spectrometry/mass spectrometry (LC-MS/MS), established cutoff values for PA diagnosis using the aldosterone-to-renin ratio (ARR) with PAC_CLEIA, and assessed the differences in PAC values by measuring weak mineralocorticoids (WMs). This retrospective study evaluated 312 serum PAC samples using RIA, CLEIA, and LC-MS/MS, and analyzed 315 plasma renin samples. Method correlations were assessed through Passing-Bablok regression. Receiver operating characteristic curves determined ARR cutoffs for PA diagnosis. WMs were quantified to evaluate their impact on ΔPAC (RIA-LC-MS/MS) through multiple regression analysis. PAC_CLEIA and PAC_LC-MS/MS values were highly correlated. ARRs derived from PAC_RIAs demonstrated more false positives and lower specificity than ARRs using PAC_CLEIA or PAC_LC-MS/MS. WMs significantly influenced ΔPAC in both the PA and non-PA groups. ARRs using PAC_CLEIA are valuable for determining PA cutoffs in clinical practice. The transition to PAC using CLEIA may enhance PA detection rates. WMs were found to interfere with PAC measurements in the RIA method, affecting outcomes.

摘要

从放射免疫分析(RIA)到化学发光酶免疫分析(CLEIA)检测血浆醛固酮浓度(PAC)的转变引起了人们对其对原发性醛固酮增多症(PA)诊断影响的关注。本研究使用 RIA、CLEIA 和液相色谱/质谱/质谱(LC-MS/MS)研究了 PAC 和肾素值之间的相关性,使用 PAC_CLEIA 建立了醛固酮与肾素比值(ARR)用于 PA 诊断的截止值,并通过测量弱盐皮质激素(WMs)评估了 PAC 值的差异。这项回顾性研究使用 RIA、CLEIA 和 LC-MS/MS 评估了 312 个血清 PAC 样本,并分析了 315 个血浆肾素样本。通过 Passing-Bablok 回归评估方法相关性。接收者操作特征曲线确定 ARR 用于 PA 诊断的截止值。通过多元回归分析评估 WM 对 ΔPAC(RIA-LC-MS/MS)的影响,以定量 WM。PAC_CLEIA 和 PAC_LC-MS/MS 值高度相关。与使用 PAC_CLEIA 或 PAC_LC-MS/MS 的 ARR 相比,PAC_RIA 衍生的 ARRs 显示出更多的假阳性和较低的特异性。WM 对 PA 和非 PA 组的 ΔPAC 均有显著影响。在临床实践中,使用 PAC_CLEIA 的 ARR 有助于确定 PA 的截止值。向 CLEIA 检测 PAC 的转变可能会提高 PA 的检出率。WM 被发现会干扰 RIA 方法中的 PAC 测量,从而影响结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/8ab854ebc1e2/41598_2024_75645_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/6282736a24d4/41598_2024_75645_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/c37ed765f0bb/41598_2024_75645_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/4843117e29ef/41598_2024_75645_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/8ab854ebc1e2/41598_2024_75645_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/6282736a24d4/41598_2024_75645_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/c37ed765f0bb/41598_2024_75645_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/4843117e29ef/41598_2024_75645_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004a/11522277/8ab854ebc1e2/41598_2024_75645_Fig4_HTML.jpg

相似文献

1
Comparative analysis of aldosterone and renin assays for primary aldosteronism screening.醛固酮与肾素检测用于原发性醛固酮增多症筛查的对比分析。
Sci Rep. 2024 Oct 29;14(1):26040. doi: 10.1038/s41598-024-75645-1.
2
Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism.原发性醛固酮增多症中化学发光酶免疫测定作为放射免疫测定的首选替代方法的肾上腺静脉采血标准。
Endocr J. 2024 May 23;71(5):461-469. doi: 10.1507/endocrj.EJ23-0695. Epub 2024 Feb 28.
3
Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan.通过在日本冲绳的回顾性分析,研究了用于测量血浆醛固酮浓度(PAC)的放射免疫分析(RIA)向化学发光酶免疫分析(CLEIA)的转变对原发性醛固酮增多症(PA)诊断的影响。
Endocr J. 2024 Sep 2;71(9):895-906. doi: 10.1507/endocrj.EJ24-0227. Epub 2024 Jun 21.
4
Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.醛固酮 LC-MS/MS 检测法在原发性醛固酮增多症筛查和确证试验中的特异性截断值。
J Clin Endocrinol Metab. 2018 Nov 1;103(11):3965-3973. doi: 10.1210/jc.2018-01041.
5
Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.在原发性醛固酮增多症的筛查和诊断中,自动化化学发光免疫分析仪与传统放射免疫分析比较血浆醛固酮和肾素数据。
PLoS One. 2021 Jul 9;16(7):e0253807. doi: 10.1371/journal.pone.0253807. eCollection 2021.
6
Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.基于液相色谱-串联质谱法测定血浆醛固酮浓度诊断原发性醛固酮增多症的标准。
J Hypertens. 2018 Jul;36(7):1592-1601. doi: 10.1097/HJH.0000000000001735.
7
Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood.用于血液中醛固酮测量的标准化液相色谱-质谱/质谱(LC-MS/MS)与化学发光酶免疫分析法的比较和可互换性研究。
Endocr J. 2022 Jan 28;69(1):45-54. doi: 10.1507/endocrj.EJ21-0278. Epub 2021 Jul 22.
8
Screening Cutoff Values for the Detection of Aldosterone-Producing Adenoma by LC-MS/MS and a Novel Noncompetitive CLEIA.通过液相色谱-串联质谱法(LC-MS/MS)和新型非竞争性化学发光酶免疫分析(CLEIA)检测醛固酮瘤的筛查临界值
J Endocr Soc. 2024 Apr 20;8(6):bvae080. doi: 10.1210/jendso/bvae080. eCollection 2024 Apr 6.
9
Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.液相色谱-串联质谱法检测醛固酮与自动直接肾素检测相结合用于原发性醛固酮增多症的筛查
Clin Chim Acta. 2014 Jun 10;433:209-15. doi: 10.1016/j.cca.2014.03.015. Epub 2014 Mar 22.
10
Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.一种新型化学发光免疫分析法检测血浆醛固酮用于原发性醛固酮增多症诊断的改变对其的影响。
Endocr J. 2023 May 29;70(5):489-500. doi: 10.1507/endocrj.EJ22-0585. Epub 2023 Mar 16.

引用本文的文献

1
Establishment and Validation of Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Aldosterone Quantification in Feline Serum with Reference Interval Determination.用于猫血清中醛固酮定量的灵敏液相色谱-串联质谱法的建立与验证及参考区间测定
Animals (Basel). 2025 Jun 6;15(12):1687. doi: 10.3390/ani15121687.
2
Measurement accuracy and cutoffs for predicting primary aldosteronism diagnosis using Lumipulse® for renin and aldosterone measurements.使用Lumipulse®进行肾素和醛固酮测量来预测原发性醛固酮增多症诊断的测量准确性及临界值。
PLoS One. 2025 Feb 25;20(2):e0319219. doi: 10.1371/journal.pone.0319219. eCollection 2025.
3

本文引用的文献

1
Screening Cutoff Values for the Detection of Aldosterone-Producing Adenoma by LC-MS/MS and a Novel Noncompetitive CLEIA.通过液相色谱-串联质谱法(LC-MS/MS)和新型非竞争性化学发光酶免疫分析(CLEIA)检测醛固酮瘤的筛查临界值
J Endocr Soc. 2024 Apr 20;8(6):bvae080. doi: 10.1210/jendso/bvae080. eCollection 2024 Apr 6.
2
Recent progress in the diagnosis and treatment of primary aldosteronism.原发性醛固酮增多症的诊治进展。
Hypertens Res. 2023 Jul;46(7):1738-1744. doi: 10.1038/s41440-023-01288-w. Epub 2023 May 17.
3
Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.
Editorial: Advances in diagnostics and management of adrenal tumors.
社论:肾上腺肿瘤诊断与管理的进展
Front Endocrinol (Lausanne). 2025 Jan 30;16:1543773. doi: 10.3389/fendo.2025.1543773. eCollection 2025.
一种新型化学发光免疫分析法检测血浆醛固酮用于原发性醛固酮增多症诊断的改变对其的影响。
Endocr J. 2023 May 29;70(5):489-500. doi: 10.1507/endocrj.EJ22-0585. Epub 2023 Mar 16.
4
The spectrum of plasma renin activity and hypertension diseases: Utility, outlook, and suggestions.血浆肾素活性与高血压疾病谱:实用性、前景及建议。
J Clin Lab Anal. 2022 Nov;36(11):e24738. doi: 10.1002/jcla.24738. Epub 2022 Oct 25.
5
Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism.醛固酮、肾素和醛固酮-肾素比值变化在原发性醛固酮增多症筛查中的应用。
J Clin Endocrinol Metab. 2022 Dec 17;108(1):33-41. doi: 10.1210/clinem/dgac568.
6
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.日本内分泌学会2021年原发性醛固酮增多症诊断与管理临床实践指南
Endocr J. 2022 Apr 28;69(4):327-359. doi: 10.1507/endocrj.EJ21-0508. Epub 2022 Apr 12.
7
Diagnosis and treatment of primary aldosteronism.原发性醛固酮增多症的诊断与治疗。
Lancet Diabetes Endocrinol. 2021 Dec;9(12):876-892. doi: 10.1016/S2213-8587(21)00210-2.
8
Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood.用于血液中醛固酮测量的标准化液相色谱-质谱/质谱(LC-MS/MS)与化学发光酶免疫分析法的比较和可互换性研究。
Endocr J. 2022 Jan 28;69(1):45-54. doi: 10.1507/endocrj.EJ21-0278. Epub 2021 Jul 22.
9
A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin II in human plasma.一种基于液相色谱-串联质谱(LC-MS/MS)的方法,用于同时定量测定人血浆中的醛固酮、肾素活性和血管紧张素 II。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Aug 1;1179:122740. doi: 10.1016/j.jchromb.2021.122740. Epub 2021 Jul 3.
10
Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.在原发性醛固酮增多症的筛查和诊断中,自动化化学发光免疫分析仪与传统放射免疫分析比较血浆醛固酮和肾素数据。
PLoS One. 2021 Jul 9;16(7):e0253807. doi: 10.1371/journal.pone.0253807. eCollection 2021.